Accepted for Publication: April 21, 2021.
Published Online: May 12, 2021. doi:10.1001/jamasurg.2021.1555
Corresponding Author: Camiel Rosman, MD, PhD (camiel.rosman@radboudumc.nl), and Moniek H. P. Verstegen, MD (moniek.verstegen@radboudumc.nl), Department of Surgery, Radboud Institute of Health Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, the Netherlands.
Author Contributions: Dr Rosman had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Drs van Workum and Verstegen contributed equally to this article and are co–first authors.
Concept and design: van Workum, Verstegen, Bouwense, van Berge Henegouwen, Daams, Gisbertz, Hannink, Heisterkamp, Jansen, van Lanschot, Nieuwenhuijzen, van der Peet, Polat, Rovers, Rosman.
Acquisition, analysis, or interpretation of data: van Workum, Verstegen, Klarenbeek, van Berge Henegouwen, Daams, Gisbertz, Hannink, Haveman, Heisterkamp, Kouwenhoven, van Lanschot, van der Peet, Ubels, Wijnhoven, Rovers, Rosman.
Drafting of the manuscript: van Workum, Verstegen, Bouwense, Hannink, Jansen, van der Peet, Ubels, Rosman.
Critical revision of the manuscript for important intellectual content: van Workum, Verstegen, Klarenbeek, Bouwense, van Berge Henegouwen, Daams, Gisbertz, Hannink, Haveman, Heisterkamp, Kouwenhoven, van Lanschot, Nieuwenhuijzen, van der Peet, Polat, Ubels, Wijnhoven, Rovers, Rosman.
Statistical analysis: van Workum, Verstegen, Bouwense, Hannink, Ubels, Rosman.
Obtained funding: van Workum, Rovers, Rosman.
Administrative, technical, or material support: van Workum, Verstegen, Bouwense, van Berge Henegouwen, Daams, Gisbertz, Heisterkamp, Jansen, Kouwenhoven, Polat, Ubels, Wijnhoven.
Supervision: van Workum, Klarenbeek, Gisbertz, Hannink, Haveman, Heisterkamp, van der Peet, Polat, Rovers, Rosman.
Conflict of Interest Disclosures: Dr Verstegen reported grants from Netherlands Organization for Health Research (ZonMw) during the conduct of the study. Dr van Berge Henegouwen reported personal fees to his institution from Mylan, Alesi Surgical, Johnson & Johnson, and Medtronic outside the submitted work and grants paid to his institution from Olympus and Stryker outside the submitted work. Dr Ubels reported grants from ZonMw during the conduct of the study and grants from Medtronic outside the submitted work. Dr Rovers reported grants from ZonMw during the conduct of the study and outside the submitted work and grants from Siemens Healthineers outside the submitted work. Dr Rosman reported grants from ZonMw during the conduct of the study. No other disclosures were reported.
Funding/Support: The Netherlands Organization for Health Research Development Health Care Efficiency Research program (ZonMw; grant 843002607) financially supported this trial.
Role of the Funder/Sponsor: ZonMw had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Group Information: The members of the ICAN collaborative research group appear in Supplement 4.
Data Sharing Statement: See Supplement 3.
Additional Contributions: We thank Tjarda Tromp, research nurse, and Marianne Stenstra, MD, Radboud University Medical Center, for their support in coordinating this trial and Marja Bulte-ter Meer, PhD, Radboud University Medical Center, for designing the figure used in the visual abstract. We thank Henk Hartgrink, MD, PhD, Leiden University Medical Center, Ton de Haan, MSc, Radboud University Medical Center, and Hein Gooszen, MD, PhD, Radboud University Medical Center, for their role as member of the data safety monitoring board.
1.Bray
F , Ferlay
J , Soerjomataram
I , Siegel
RL , Torre
LA , Jemal
A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2018;68(6):394-424. doi:
10.3322/caac.21492
PubMedGoogle ScholarCrossref 2.Al-Batran
SE , Homann
N , Pauligk
C ,
et al; FLOT4-AIO Investigators. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Lancet. 2019;393(10184):1948-1957. doi:
10.1016/S0140-6736(18)32557-1
PubMedGoogle ScholarCrossref 6.Biere
SS , Maas
KW , Cuesta
MA , van der Peet
DL . Cervical or thoracic anastomosis after esophagectomy for cancer: a systematic review and meta-analysis.
Dig Surg. 2011;28(1):29-35. doi:
10.1159/000322014
PubMedGoogle ScholarCrossref 7.Alanezi
K , Urschel
JD . Mortality secondary to esophageal anastomotic leak.
Ann Thorac Cardiovasc Surg. 2004;10(2):71-75.
PubMedGoogle Scholar 9.Markar
S , Gronnier
C , Duhamel
A ,
et al; FREGAT (French Eso-Gastric Tumors) working group, FRENCH (Fédération de Recherche EN CHirurgie), and AFC (Association Française de Chirurgie). The impact of severe anastomotic leak on long-term survival and cancer recurrence after surgical resection for esophageal malignancy.
Ann Surg. 2015;262(6):972-980. doi:
10.1097/SLA.0000000000001011
PubMedGoogle ScholarCrossref 11.Mariette
C , Markar
SR , Dabakuyo-Yonli
TS ,
et al; Fédération de Recherche en Chirurgie (FRENCH) and French Eso-Gastric Tumors (FREGAT) Working Group. Hybrid minimally invasive esophagectomy for esophageal cancer.
N Engl J Med. 2019;380(2):152-162. doi:
10.1056/NEJMoa1805101
PubMedGoogle ScholarCrossref 12.Straatman
J , van der Wielen
N , Cuesta
MA ,
et al. Minimally invasive versus open esophageal resection: three-year follow-up of the previously reported randomized controlled trial: the TIME trial.
Ann Surg. 2017;266(2):232-236. doi:
10.1097/SLA.0000000000002171
PubMedGoogle ScholarCrossref 13.Haverkamp
L , Seesing
MF , Ruurda
JP , Boone
J , V Hillegersberg
R . Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
Dis Esophagus. 2017;30(1):1-7.
PubMedGoogle Scholar 16.van Workum
F , Berkelmans
GH , Klarenbeek
BR , Nieuwenhuijzen
GAP , Luyer
MDP , Rosman
C . McKeown or Ivor Lewis totally minimally invasive esophagectomy for cancer of the esophagus and gastroesophageal junction: systematic review and meta-analysis.
J Thorac Dis. 2017;9(suppl 8):S826-S833. doi:
10.21037/jtd.2017.03.173
PubMedGoogle ScholarCrossref 18.Gooszen
JAH , Goense
L , Gisbertz
SS , Ruurda
JP , van Hillegersberg
R , van Berge Henegouwen
MI . Intrathoracic versus cervical anastomosis and predictors of anastomotic leakage after oesophagectomy for cancer.
Br J Surg. 2018;105(5):552-560. doi:
10.1002/bjs.10728
PubMedGoogle ScholarCrossref 19.van Workum
F , Bouwense
SA , Luyer
MD ,
et al. Intrathoracic versus cervical anastomosis after minimally invasive esophagectomy for esophageal cancer: study protocol of the ICAN randomized controlled trial.
Trials. 2016;17(1):505. doi:
10.1186/s13063-016-1636-2
PubMedGoogle ScholarCrossref 21.van Workum
F , van den Wildenberg
FJ , Polat
F , de Wilt
JH , Rosman
C . Minimally invasive oesophagectomy: preliminary results after introduction of an intrathoracic anastomosis.
Dig Surg. 2014;31(2):95-103. doi:
10.1159/000358812
PubMedGoogle ScholarCrossref 23.Castor EDC. The scalable decentralized and hybrid clinical trial platform: castor electronic data capture 2019. Published August 27, 2019. Accessed April 7, 2021.
http://www.castoredc.com.
24.Low
DE , Alderson
D , Cecconello
I ,
et al. International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG).
Ann Surg. 2015;262(2):286-294. doi:
10.1097/SLA.0000000000001098
PubMedGoogle ScholarCrossref 26.Aaronson
NK , Ahmedzai
S , Bergman
B ,
et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.
J Natl Cancer Inst. 1993;85(5):365-376. doi:
10.1093/jnci/85.5.365
PubMedGoogle ScholarCrossref 27.Lagergren
P , Fayers
P , Conroy
T ,
et al; European Organisation for Research Treatment of Cancer Gastrointestinal and Quality of Life Groups. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.
Eur J Cancer. 2007;43(14):2066-2073. doi:
10.1016/j.ejca.2007.07.005
PubMedGoogle ScholarCrossref 28.Musoro
JZ , Bottomley
A , Coens
C ,
et al; EORTC Melanoma Group and EORTC Quality of Life Group. Interpreting European Organisation for Research and Treatment for Cancer Quality of Life Questionnaire Core 30 scores as minimally importantly different for patients with malignant melanoma.
Eur J Cancer. 2018;104:169-181. doi:
10.1016/j.ejca.2018.09.005
PubMedGoogle ScholarCrossref 29.Musoro
JZ , Coens
C , Fiteni
F ,
et al; EORTC Breast and Quality of Life Groups. Minimally important differences for interpreting EORTC QLQ-C30 scores in patients with advanced breast cancer.
JNCI Cancer Spectr. 2019;3(3):pkz037. doi:
10.1093/jncics/pkz037
PubMedGoogle Scholar 31.Metcalfe
C , Avery
K , Berrisford
R ,
et al. Comparing open and minimally invasive surgical procedures for oesophagectomy in the treatment of cancer: the ROMIO (Randomised Oesophagectomy: Minimally Invasive or Open) feasibility study and pilot trial.
Health Technol Assess. 2016;20(48):1-68. doi:
10.3310/hta20480
PubMedGoogle ScholarCrossref 33.Guo
W , Zou
YB , Ma
Z ,
et al. One surgeon’s learning curve for video-assisted thoracoscopic esophagectomy for esophageal cancer with the patient in lateral position: how many cases are needed to reach competence?
Surg Endosc. 2013;27(4):1346-1352. doi:
10.1007/s00464-012-2614-8
PubMedGoogle ScholarCrossref 34.Lin
J , Kang
M , Chen
C ,
et al. Thoracolaparoscopy oesophagectomy and extensive two-field lymphadenectomy for oesophageal cancer: introduction and teaching of a new technique in a high-volume centre.
Eur J Cardiothorac Surg. 2013;43(1):115-121. doi:
10.1093/ejcts/ezs151
PubMedGoogle ScholarCrossref 41.Fransen
LFC , Berkelmans
GHK , Asti
E , van Berge Henegouwen
MI , Berlth
F , Bonavina
L ,
et al The effect of postoperative complications after minimally invasive esophagectomy on long-term survival: an international multicenter cohort study.
Ann Surg. 2020. doi:
10.1097/SLA.0000000000004293
Google Scholar 42.Hulscher
JB , van Sandick
JW , de Boer
AG ,
et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus.
N Engl J Med. 2002;347(21):1662-1669. doi:
10.1056/NEJMoa022343
PubMedGoogle ScholarCrossref 43.van Heijl
M , van Wijngaarden
AK , Lagarde
SM , Busch
OR , van Lanschot
JJ , van Berge Henegouwen
MI . Intrathoracic manifestations of cervical anastomotic leaks after transhiatal and transthoracic oesophagectomy.
Br J Surg. 2010;97(5):726-731. doi:
10.1002/bjs.6971
PubMedGoogle ScholarCrossref